Analyst Ratings for XTL Biopharmaceuticals (XTLB)
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
5/8/2015 | H.C. Wainwright | N/A | New Coverage | Buy (N/A) |
6.00 (N/A) |
2.02 (2.56) |
26.73% | Details |
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
5/8/2015 | H.C. Wainwright | N/A | New Coverage | Buy (N/A) |
6.00 (N/A) |
2.02 (2.56) |
26.73% | Details |